Xeglyze

Active Ingredient(s): Abametapir
FDA Approved: * July 24, 2020
Pharm Company: * DR REDDYS LABS SA
Category: Antiprotozoal / Anthelmintic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Xeglyze Overview

Abametapir, sold under the brand name Xeglyze, is a medication used for the treatment of head lice infestation.[1] Abametapir is a metalloproteinase inhibitor.[1] Abametapir was approved for medical use in the United States in July 2020.[1][2] References ^ a b c "Xeglyze (abametapir) lotion, for topical use" (PDF). U.S. Food and Drug Administration (FDA). Dr. Reddy's Laboratories. Inc. Retrieved 25 July 2020..mw-parser-outpu...

Read more Xeglyze Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abametapir

Recent Xeglyze Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Abametapir or a similar ingredient: (1 result)

• ABAMETAPIR